COLPOSCOPY
BASIC and ADVANCED
ONLINE COURSES
World class online training courses in colposcopy and the diagnosis and treatment of cervical and lower genital tract neoplasia to help practitioners in improving the quality of colposcopy management worldwide. Approved by the British Society for Colposcopy and Cervical Pathology (BSCCP).
“Our world class online courses give medical professionals training and accreditation in colposcopy and the management of cervical and lower genital tract pre-cancer.”
Professor Albert Singer
CHOOSE A COURSE
BASIC
£495 (12 months access)
Study wherever and whenever you like. Review and revise at your convenience over 12 months.
- BSCCP & 12 hours CME approved
- Optional quiz at end of each module
- Audio, visual and annotated images
ADVANCED
£695 (12 months access) or £500 for Basic Course students
The latest techniques in colposcopy and management of cervical and lower genital tract neoplasia.
- Contributions by international experts
- Audiovisual and interactive elements
- Discussion of most recent research
GET BOTH COURSES FOR £995
Buy 12 months access to the Basic and Advanced courses for £995, saving you £100 on the combined individual prices.
Previous students of the Basic course can buy the Advanced Course for £500. Email for discount code.
COURSE PREVIEW
Watch the video below to see examples of our learning from the Basic course. Click here to get a free preview of the course.
LATEST NEWS
World Cancer Day: Inequality will prevent elimination of cervical cancer
By Professor Albert Singer Cervical cancer is the leading cause of cancer deaths in women in more than 40 countries. The prospect of cervical cancer becoming a rare disease is one of the most exciting things after having spent more than 50 years treating and...
The clear case for self-collection in cervical cancer screening
Screening is absolutely critical to reducing cervical cancer but many women are not going for their screening tests during the pandemic. Early precancerous changes are 95% curable with one simple treatment but if they are not identified in a screening, over 10 years they will develop into cancer in around 30% of women. The case for an alternative or supplement to in-person screening is clear. Self-collection kits in the form of self-sample brush sticks or first void urine samples have been shown to be as effective as those collected by a physician.
The fight against cervical cancer and HPV in the Pandemic
For those concerned with eliminating cervical cancer, the effects of the COVID-19 response are extremely concerning. Challenges include reduced or delayed screening; the issue plummeting down governments’ agenda; and scarce supplies of the HPV vaccine. Professor Singer considers the impact of these changes and offers two limited solutions that may help keep our battle against cervical cancer on track.
APPROVED BY
